{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:07:19Z","timestamp":1773281239367,"version":"3.50.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/iop.0b013e31829f3b46","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T12:28:30Z","timestamp":1399638510000},"page":"e84-e85","source":"Crossref","is-referenced-by-count":15,"title":["Nitrogen Bisphosphonate-induced Orbital Inflammatory Disease"],"prefix":"10.1097","volume":"30","author":[{"given":"Monisha M.","family":"Vora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Rand","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Uretsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-28-20210129","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archopht.121.9.1335","article-title":"Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer.","volume":"121","author":"Subramanian","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R2-28-20210129","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis.","volume":"95","author":"Watts","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-28-20210129","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMc0803366","article-title":"Zoledronic acid infusion and orbital inflammatory disease.","volume":"359","author":"Sharma","year":"2008","journal-title":"N Engl J Med"},{"key":"R4-28-20210129","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM200303203481225","article-title":"Bisphosphonates and ocular inflammation.","volume":"348","author":"Fraunfelder","year":"2003","journal-title":"N Engl J Med"},{"key":"R5-28-20210129","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12032-007-9006-2","article-title":"A case report: zoledronic acid-induced anterior uveitis.","volume":"25","author":"Kilickap","year":"2008","journal-title":"Med Oncol"},{"key":"R6-28-20210129","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.clon.2006.04.013","article-title":"Serious ocular complications of zoledronate.","volume":"18","author":"Woo","year":"2006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R7-28-20210129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/01676830.2011.648818","article-title":"Bisphosphonate-associated orbital inflammationa case report and review.","volume":"31","author":"Peterson","year":"2012","journal-title":"Orbit"},{"key":"R8-28-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/01676830.2010.535641","article-title":"Two cases of drug-induced orbital inflammatory disease.","volume":"30","author":"Ortiz-Perez","year":"2011","journal-title":"Orbit"},{"key":"R9-28-20210129","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.4158\/EP11081.CR","article-title":"Orbital inflammatory disease in a patient treated with zolendronate.","volume":"17","author":"Kaur","year":"2011","journal-title":"Endocr Pract"},{"key":"R10-28-20210129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/WNO.0b013e3181c1a589","article-title":"Another case of bisphosphonate-induced orbital inflammation.","volume":"30","author":"Yang","year":"2010","journal-title":"J Neuroophthalmol"},{"key":"R11-28-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archophthalmol.2007.17","article-title":"Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma.","volume":"126","author":"Phillips","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R12-28-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2567.2000.00122.x","article-title":"An alphabeta T-cell-independent immunoprotective response towards gut coccidia is supported by gammadelta cells.","volume":"101","author":"Smith","year":"2000","journal-title":"Immunology"},{"key":"R13-28-20210129","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1097\/01.ju.0000154355.45816.0b","article-title":"Ex vivo expanded human Vgamma9Vdelta2 gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro.","volume":"173","author":"Liu","year":"2005","journal-title":"J Urol"}],"container-title":["Ophthalmic Plastic & Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0b013e31829f3b46","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:55:11Z","timestamp":1620957311000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002341-201407000-00028"}},"subtitle":["Gamma Delta T Cells\u2014A Report and Review of 2 Cases"],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0b013e31829f3b46","relation":{},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}